A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY

Clinical trial NCT01018732 · COMPLETED

Trial details

NCT number: NCT01018732
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningococcal Disease Meningococcal Meningitis

Start date: 2010-01-01
Primary completion: 2010-07-01
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.